Goodwill and Other Intangible Assets (Details Narrative) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Jul. 15, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Goodwill | $ 8,433,000 | $ 8,433,000 | ||
| Identifiable intangible assets | $ 7,300,000 | |||
| Amortization expense | $ 6,000,000 | $ 4,000,000 | ||
| BioPharma Acquisition [Member] | ||||
| Intangible assets | 15,600,000 | |||
| Goodwill | 8,273,000 | |||
| Identifiable intangible assets | $ 7,300,000 | |||
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|